Cg Oncology

(NASDAQ) CGON

Current Price$68.83

Market Cap$5.74B

Since IPO (2024)+83%

5 YearN/A

1 Year+213%

1 Month+1%

Cg Oncology Financials at a Glance

Market Cap

$5.74B

Revenue (TTM)

$4.04M

Net Income (TTM)

$161.00M

EPS (TTM)

$-2.08

P/E Ratio

-32.66

Dividend

$0.00

Beta (Volatility)

1.53 (High)

Dividend

$0.00

Beta (Volatility)

1.53 (High)

Price

$68.83

Volume

141,304.566

Open

$68.16

Price

$68.83

Volume

141,304.566

Open

$68.16

Previous Close

$68.01

Daily Range

$67.84 - $69.41

52-Week Range

$21.90 - $73.56

Dividend

$0.00

Beta (Volatility)

1.53 (High)

Price

$68.83

Volume

141,304.566

Open

$68.16

Previous Close

$68.01

Daily Range

$67.84 - $69.41

52-Week Range

$21.90 - $73.56

CGON News

This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know

Jonathan PoncianoMar 21, 2026

CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale

Jonathan PoncianoFeb 19, 2026

Person in a lab gazing into a microscope

Why Cg Oncology Stock Rocketed 7% Higher Today

Eric VolkmanOct 8, 2025

Cg Oncology (CGON) Q2 Loss Widens 93%

Motley Fool Markets TeamAug 8, 2025

CGON: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cg Oncology

Industry

Biotechnology

Sector

Health Care

Employees

142

CEO

Arthur Kuan

Website

www.cgoncology.com

Headquarters

Irvine, DE, US

CGON Financials

Key Financial Metrics (TTM)

Gross Margin

-15%

Operating Margin

-47%

Net Income Margin

-40%

Return on Equity

-22%

Return on Capital

-25%

Return on Assets

-20%

Earnings Yield

-3.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.74B

Shares Outstanding

84.44M

Volume

141.30K

Avg. Volume

1.18M

Financials (TTM)

Gross Profit

$607.00K

Operating Income

$190.77M

EBITDA

$159.55M

Operating Cash Flow

$132.35M

Capital Expenditure

$134.00K

Free Cash Flow

$132.48M

Cash & ST Invst.

$742.15M

Total Debt

$7.02M

Cg Oncology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$2.32M

+409.2%

Gross Profit

$592.00K

-229.8%

Gross Margin

-25.50%

N/A

Market Cap

$5.74B

N/A

Market Cap/Employee

$50.82M

N/A

Employees

113

N/A

Net Income

$41.31M

-29.9%

EBITDA

$40.46M

-6.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$735.13M

-0.9%

Accounts Receivable

$688.00K

-11.9%

Inventory

$1.56M

N/A

Long Term Debt

$6.11M

+11642.3%

Short Term Debt

$915.00K

+391.9%

Return on Assets

-20.34%

N/A

Return on Invested Capital

-25.08%

N/A

Free Cash Flow

$36.22M

-73.6%

Operating Cash Flow

$36.22M

-75.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CNTACentessa Pharmaceuticals plc

CNTACentessa Pharmaceuticals plc$39.59-0.04%

LEGNLegend Biotech Corporation

LEGNLegend Biotech Corporation$28.80-0.55%

CELCCelcuity Inc.

CELCCelcuity Inc.$131.75-5.51%

APGEApogee Therapeutics, Inc.

APGEApogee Therapeutics, Inc.$82.60-2.29%

XENEXenon Pharmaceuticals Inc.

XENEXenon Pharmaceuticals Inc.$57.15-2.46%

TVTXTravere Therapeutics, Inc.

TVTXTravere Therapeutics, Inc.$44.27-1.09%

TARSTarsus Pharmaceuticals, Inc.

TARSTarsus Pharmaceuticals, Inc.$61.27-5.39%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.40+0.06%

SNAPSnap

SNAPSnap$6.13+0.00%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$8.49+0.65%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$72.83+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$44.80-0.02%

PTONPeloton Interactive

PTONPeloton Interactive$5.61+0.08%

CORZCore Scientific

CORZCore Scientific$22.20-0.10%

Questions About CGON

What is the current price of Cg Oncology?

Cg Oncology is trading at $69.24 per share.

What is the 52-week range for Cg Oncology?

Over the past 52 weeks, Cg Oncology has traded between $21.90 and $73.56.

How much debt does Cg Oncology have?

As of the most recent reporting period, Cg Oncology reported total debt of $7.02M.

How much cash does Cg Oncology have on hand?

Cg Oncology reported $32.49M in cash and cash equivalents in its most recent financial results.

What is Cg Oncology’s dividend yield?

Cg Oncology does not currently have a dividend yield.

Cg Oncology

Cg Oncology Financials at a Glance

CGON News

This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know

CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale

Why Cg Oncology Stock Rocketed 7% Higher Today

Cg Oncology (CGON) Q2 Loss Widens 93%

CGON: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cg Oncology

CGON Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cg Oncology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CGON

What is the current price of Cg Oncology?

What is the 52-week range for Cg Oncology?

How much debt does Cg Oncology have?

How much cash does Cg Oncology have on hand?

What is Cg Oncology’s dividend yield?

Premium Investing Services